Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 6

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 6
---
 the Chinese Securities Regulatory Commission (the “CSRC”) or other PRC government authorities may be required in connection with our future offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be able to complete the filing procedure with the CSRC and obtain such approval or complete such filing, as applicable” on page 14 of the accompanying prospectus and our most recent annual report on Form 20-F.

As of the date of this prospectus supplement,
according to our PRC counsel, Tianyuan Law Firm, although we are required to complete the filing procedure in connection with our offerings
under the Trial Measures, no relevant PRC laws or regulations in effect require that we obtain permission from any PRC authorities to
issue securities to foreign investors, and we have not received any inquiry, notice, warning, sanction, or any regulatory objection to
this offering from the CSRC, the CAC, or any other PRC authorities that have jurisdiction over our operations.

The Standing Committee of the National People’s
Congress, or the SCNPC, or other PRC regulatory authorities may in the future promulgate laws, regulations or implementing rules that
requires our company or any of our subsidiaries to obtain regulatory approval from Chinese authorities before listing in the U.S. In
other words, although the Company has not received any denial to list on the U.S. exchange, our operations could be adversely affected,
directly or indirectly; our ability to offer, or continue to offer, securities to investors would be potentially hindered and the value
of our securities might significantly decline or be worthless, by existing or future laws and regulations relating to its business or
industry or by intervene or interruption by PRC governmental authorities, if we or our subsidiaries (i) do not receive or maintain
such permissions or approvals, (ii) inadvertently conclude that such permissions or approvals are not required, (iii) applicable
laws, regulations, or interpretations change and we are required to obtain such permissions or approvals in the future, or (iv) any
intervention or interruption by PRC governmental with little advance notice. See “Risk Factors — Risks
Related to Doing Business in China” beginning on page 13 of the accompanying prospectus and our most recent annual report on
Form 20-F for a discussion of these legal and operational risks and information that should be considered before making a decision to
purchase our Class A ordinary shares.

In addition, since 2021, the Chinese government
has strengthened